Finasteride: Long-term survival of participants in prostate cancer prevention trial detailed

Initial findings from a decade ago showed that the drug finasteride significantly reduced the risk of prostate cancer, but among those who did develop prostate cancer, paradoxically, the drug was associated with an increased risk of high-grade disease. Long term results show the small excess of higher grade tumors in the men in the finasteride arm of the study did not translate into an increased risk of death.

Read the whole article on Science Daily

More from Science Daily